Loading…

Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors

This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess...

Full description

Saved in:
Bibliographic Details
Published in:Ciência & saude coletiva 2019-12, Vol.24 (12), p.4717
Main Authors: Ferreira, Danielle Portella, Chaves, Célia Regina Moutinho de Miranda, Costa, Ana Carolina Carioca da
Format: Article
Language:Portuguese
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 12
container_start_page 4717
container_title Ciência & saude coletiva
container_volume 24
creator Ferreira, Danielle Portella
Chaves, Célia Regina Moutinho de Miranda
Costa, Ana Carolina Carioca da
description This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.
doi_str_mv 10.1590/1413-812320182412.31622017
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_31778521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31778521</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203</originalsourceid><addsrcrecordid>eNo1j0tLAzEURoMgtlb_ggT3U3Nvkpkbd6X4goIbXZc0c0NH5sUkIuOvt6CuPg4cDnxC3IJag3XqDgzoggA1KiA0gGsNJZ6gOhNLKCsqjC1hIS5T-lAKK23wQiw0VBVZhKXYb-ojT9wHlkOUvh5aToH7nORXk48yzCk3QcbmMA2pSTIPkvvvuWM58dj6wN3JlfmU8ON8L31KQ2h85lpGH_IwpStxHn2b-PpvV-L98eFt-1zsXp9etptdMYKiXHhDVmmNpQbL_oDkgDxFChBL4xxh0LU3UWlnbQCranLEaAmdKbVHpVfi5rc7fh46rvfj1HR-mvf_T_UP5XBV7Q</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><source>SciELO Brazil</source><source>Publicly Available Content Database</source><creator>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</creator><creatorcontrib>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</creatorcontrib><description>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</description><identifier>EISSN: 1678-4561</identifier><identifier>DOI: 10.1590/1413-812320182412.31622017</identifier><identifier>PMID: 31778521</identifier><language>por</language><publisher>Brazil</publisher><subject>Adolescent ; Child ; Cross-Sectional Studies ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - therapy ; Early Diagnosis ; Enzyme Replacement Therapy - statistics &amp; numerical data ; Female ; Humans ; Male ; Medication Adherence - statistics &amp; numerical data ; Surveys and Questionnaires ; Young Adult</subject><ispartof>Ciência &amp; saude coletiva, 2019-12, Vol.24 (12), p.4717</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-9456-3319 ; 0000-0002-2659-720X ; 0000-0002-6727-188X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31778521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreira, Danielle Portella</creatorcontrib><creatorcontrib>Chaves, Célia Regina Moutinho de Miranda</creatorcontrib><creatorcontrib>Costa, Ana Carolina Carioca da</creatorcontrib><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><title>Ciência &amp; saude coletiva</title><addtitle>Cien Saude Colet</addtitle><description>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</description><subject>Adolescent</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - therapy</subject><subject>Early Diagnosis</subject><subject>Enzyme Replacement Therapy - statistics &amp; numerical data</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medication Adherence - statistics &amp; numerical data</subject><subject>Surveys and Questionnaires</subject><subject>Young Adult</subject><issn>1678-4561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1j0tLAzEURoMgtlb_ggT3U3Nvkpkbd6X4goIbXZc0c0NH5sUkIuOvt6CuPg4cDnxC3IJag3XqDgzoggA1KiA0gGsNJZ6gOhNLKCsqjC1hIS5T-lAKK23wQiw0VBVZhKXYb-ojT9wHlkOUvh5aToH7nORXk48yzCk3QcbmMA2pSTIPkvvvuWM58dj6wN3JlfmU8ON8L31KQ2h85lpGH_IwpStxHn2b-PpvV-L98eFt-1zsXp9etptdMYKiXHhDVmmNpQbL_oDkgDxFChBL4xxh0LU3UWlnbQCranLEaAmdKbVHpVfi5rc7fh46rvfj1HR-mvf_T_UP5XBV7Q</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Ferreira, Danielle Portella</creator><creator>Chaves, Célia Regina Moutinho de Miranda</creator><creator>Costa, Ana Carolina Carioca da</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0002-9456-3319</orcidid><orcidid>https://orcid.org/0000-0002-2659-720X</orcidid><orcidid>https://orcid.org/0000-0002-6727-188X</orcidid></search><sort><creationdate>201912</creationdate><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><author>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - therapy</topic><topic>Early Diagnosis</topic><topic>Enzyme Replacement Therapy - statistics &amp; numerical data</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medication Adherence - statistics &amp; numerical data</topic><topic>Surveys and Questionnaires</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, Danielle Portella</creatorcontrib><creatorcontrib>Chaves, Célia Regina Moutinho de Miranda</creatorcontrib><creatorcontrib>Costa, Ana Carolina Carioca da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Ciência &amp; saude coletiva</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreira, Danielle Portella</au><au>Chaves, Célia Regina Moutinho de Miranda</au><au>Costa, Ana Carolina Carioca da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</atitle><jtitle>Ciência &amp; saude coletiva</jtitle><addtitle>Cien Saude Colet</addtitle><date>2019-12</date><risdate>2019</risdate><volume>24</volume><issue>12</issue><spage>4717</spage><pages>4717-</pages><eissn>1678-4561</eissn><abstract>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</abstract><cop>Brazil</cop><pmid>31778521</pmid><doi>10.1590/1413-812320182412.31622017</doi><orcidid>https://orcid.org/0000-0002-9456-3319</orcidid><orcidid>https://orcid.org/0000-0002-2659-720X</orcidid><orcidid>https://orcid.org/0000-0002-6727-188X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1678-4561
ispartof Ciência & saude coletiva, 2019-12, Vol.24 (12), p.4717
issn 1678-4561
language por
recordid cdi_pubmed_primary_31778521
source SciELO Brazil; Publicly Available Content Database
subjects Adolescent
Child
Cross-Sectional Studies
Cystic Fibrosis - diagnosis
Cystic Fibrosis - therapy
Early Diagnosis
Enzyme Replacement Therapy - statistics & numerical data
Female
Humans
Male
Medication Adherence - statistics & numerical data
Surveys and Questionnaires
Young Adult
title Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A03%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20of%20adolescents%20with%20cystic%20fibrosis%20to%20enzyme%20replacement%20therapy:%20associated%20factors&rft.jtitle=Ci%C3%AAncia%20&%20saude%20coletiva&rft.au=Ferreira,%20Danielle%20Portella&rft.date=2019-12&rft.volume=24&rft.issue=12&rft.spage=4717&rft.pages=4717-&rft.eissn=1678-4561&rft_id=info:doi/10.1590/1413-812320182412.31622017&rft_dat=%3Cpubmed%3E31778521%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/31778521&rfr_iscdi=true